Search

Showing total 134 results

Search Constraints

Start Over You searched for: Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years Journal vaccine Remove constraint Journal: vaccine Publisher elsevier bv Remove constraint Publisher: elsevier bv
134 results

Search Results

3. Measles vaccines: WHO position paper, April 2017 – Recommendations

4. Introductory paper: High-dose influenza vaccine

5. Rabies vaccines: WHO position paper, April 2018 – Recommendations

6. Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations

8. Writing a scientific paper—A brief guide for new investigators

10. New recommendations to prevent pain during immunizations: WHO position paper – September 2015

13. Dengue vaccine: WHO position paper, July 2016 – recommendations

17. Japanese Encephalitis Vaccines: WHO position paper, February 2015 – Recommendations

21. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink

24. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013—Recommendations

26. Sustainable financing for Immunization Agenda 2030

27. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines

28. Assessment of VaxTrac electronic immunization registry in an urban district in Sierra Leone: Implications for data quality, defaulter tracking, and policy

29. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability

30. Experiential and authentic learning approaches in vaccine management

31. Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination

32. Corrigendum to 'An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature' [Vaccine 36(21) 3054–3060]

33. Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC)

34. Enhanced passive safety surveillance of Influvac® and Influvac® Tetra: Results from seven consecutive seasons

35. Flexible analytic model to inform multi-stakeholder pediatric vaccine scheduling decisions

36. A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia

37. Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa

38. A retrospective evaluation of side‐effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID‐19 vaccine among females in Eastern Province, Saudi Arabia

39. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

40. 'Every interaction you have …should be an opportunity to discuss and offer influenza vaccination'. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families living in New South Wales, Australia

41. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

42. Regulatory considerations for study of infant protection through maternal immunization

43. Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine

44. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review

45. Non-specific effects of veterinary vaccines: a systematic review

46. Social media use and vaccine hesitancy in the European Union

47. Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo

48. Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly

49. Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12–13 February 2020

50. Transforming the vaccine supply chain in Australia: Opportunities and challenges